ArticleOncology letters2019
miR-106a contributes to prostate carcinoma progression through PTEN.
Ji Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncology letters2019
Ji Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.